Paradigm Medical Industries, Inc.
PDMI · OTC
12/31/2011 | 12/31/2010 | 12/31/2009 | 12/31/2008 | |
|---|---|---|---|---|
| Revenue | $772 | $726 | $858 | $1,259 |
| % Growth | 6.3% | -15.4% | -31.9% | – |
| Cost of Goods Sold | $247 | $311 | $408 | $704 |
| Gross Profit | $525 | $415 | $450 | $555 |
| % Margin | 68% | 57.2% | 52.4% | 44.1% |
| R&D Expenses | $260 | $355 | $243 | $255 |
| G&A Expenses | $479 | $619 | $524 | $0 |
| SG&A Expenses | $595 | $894 | $729 | $1,422 |
| Sales & Mktg Exp. | $116 | $275 | $205 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $855 | $1,249 | $972 | $1,677 |
| Operating Income | $330 | $834 | $522 | $1,122 |
| % Margin | 42.7% | 114.9% | 60.8% | 89.1% |
| Other Income/Exp. Net | -$144 | -$134 | -$428 | -$607 |
| Pre-Tax Income | -$474 | -$968 | -$950 | -$1,729 |
| Tax Expense | $148 | -$1,647 | $255 | $607 |
| Net Income | -$474 | -$968 | -$950 | -$1,729 |
| % Margin | -61.4% | -133.3% | -110.7% | -137.3% |
| EPS | -0.01 | -0.021 | -0.04 | -15.17 |
| % Growth | 51% | 47.5% | 99.7% | – |
| EPS Diluted | -0.01 | -0.021 | -0.085 | -15.17 |
| Weighted Avg Shares Out | 46,429 | 46,429 | 23,994 | 114 |
| Weighted Avg Shares Out Dil | 46,429 | 46,429 | 11,208 | 114 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5 | $21 | -$3 | $3 |
| Interest Expense | $148 | $155 | $255 | $827 |
| Depreciation & Amortization | $1 | $4 | $4 | $5 |
| EBITDA | -$325 | -$809 | -$691 | -$1,117 |
| % Margin | -42.1% | -111.4% | -80.5% | -88.7% |